Commentary: Cutting the losses: Using lungs from donors with substance abuse history

[摘要] Lung transplantation remains the only viable option for many patients with end-stage lung disease. The availability of donor lungs is a well-established limitation, with 1.2 patients on the waiting list for each donor in 2019.1 In the United States, historically only 20% of donor lungs are used. The remainder either do not meet standard acceptance criteria or are considered not suitable by individual programs. There is tremendous variation in programmatic acceptance criteria, particularly when it comes to soft, unsuitable findings.

[学科分类] 心脏病和心血管学